232 related articles for article (PubMed ID: 33015779)
41. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
Xia J; Wang H; Huang H; Sun L; Dong S; Huang N; Shi M; Bin J; Liao Y; Liao W
Cancer Lett; 2016 Oct; 381(1):31-40. PubMed ID: 27431311
[TBL] [Abstract][Full Text] [Related]
42. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.
Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z
Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181
[TBL] [Abstract][Full Text] [Related]
43. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
44. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
[TBL] [Abstract][Full Text] [Related]
45. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
46. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
[TBL] [Abstract][Full Text] [Related]
47. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
48. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].
Cai C; Yu JW; Wu JG; Lu RQ; Ni XC; Wang SL; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):662-7. PubMed ID: 23888452
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
50. Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.
Cao QH; Liu F; Li CZ; Liu N; Shu M; Lin Y; Ding L; Xue L
BMC Cancer; 2018 Jan; 18(1):94. PubMed ID: 29361914
[TBL] [Abstract][Full Text] [Related]
51. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells.
Zeng C; Yan R; Yang G; Xiang S; Zhao F
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478377
[TBL] [Abstract][Full Text] [Related]
52. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
Zhang M; Wang S; Yi A; Qiao Y
Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
[TBL] [Abstract][Full Text] [Related]
53. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
54. ADAM17 promotes epithelial-mesenchymal transition via TGF-β/Smad pathway in gastric carcinoma cells.
Xu M; Zhou H; Zhang C; He J; Wei H; Zhou M; Lu Y; Sun Y; Ding JW; Zeng J; Peng W; Du F; Gong A
Int J Oncol; 2016 Dec; 49(6):2520-2528. PubMed ID: 27779657
[TBL] [Abstract][Full Text] [Related]
55. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.
Ureshino H; Murakami Y; Watari K; Izumi H; Kawahara A; Kage M; Arao T; Nishio K; Yanagihara K; Kinoshita H; Kuwano M; Ono M
PLoS One; 2012; 7(7):e41312. PubMed ID: 22844455
[TBL] [Abstract][Full Text] [Related]
56. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
[TBL] [Abstract][Full Text] [Related]
57. Antimetastatic effects of Celastrus orbiculatus on human gastric adenocarcinoma by inhibiting epithelial-mesenchymal transition and NF-κB/snail signaling pathway.
Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
Integr Cancer Ther; 2015 May; 14(3):271-81. PubMed ID: 25722220
[TBL] [Abstract][Full Text] [Related]
58. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
59. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
Dong JS; Wu B; Zha ZL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]